COMPANY NEWS IN BRIEF
BioNTech expecting billions in revenueGermany's BioNTech SE said the Covid-19 vaccine it is developing with partner Pfizer will likely generate up to 17 billion euros (US$19.6 bill
...
If you are an active subscriber and the article is not showing, please log out and back in. Free access to articles from 10:00.


Kommentaar
Republikein
Geen kommentaar is op hierdie artikel gelaat nie